Barinthus Biotherapeutics Plc. Total Liabilities

Barinthus Biotherapeutics Plc. (BRNS) currently reports a total liabilities of $25M as of June 2026. That compares with $27M in the prior-year period — down 8.6% year over year. Use the charts on this page to explore Barinthus Biotherapeutics Plc.'s total liabilities history and peer comparisons.

Barinthus Biotherapeutics Plc.'s total liabilities decreased from $27M to $25M — a 8.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Barinthus Biotherapeutics Plc. reported $25M in total liabilities as of June 2026. That compares with $27M in the prior-year period — down 8.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Barinthus Biotherapeutics Plc., and consider following BRNS for alerts when major investors trade the stock.

Barinthus Biotherapeutics Plc. is classified in the Healthcare sector. On total liabilities, it currently shows $25M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BRNS with unrelated industries.